|
| |
Advances and Achievements
Joseph Anderson, M.D. |
 |
Joseph Anderson, M.D., clinical director of the Colon Cancer Prevention
Program and an experienced gastroenterologist, contributed to new
national guidelines for colon cancer screening. The American College of
Gastroenterology now urges clinicians to take smoking and obesity into
serious consideration when making screening recommendations. “The new guidelines reflect a growing understanding
of the powerful role that lifestyle factors can play in the development
– and prevention – of colon cancer,” Dr. Anderson notes.
|
Molly Brewer, D.V.M., M.D., M.S. |
 |
Molly Brewer, D.V.M., M.D., M.S.,
director of the Division of Gynecologic Oncology and the Women’s Cancer
Prevention Program, was recently inducted into the American
Gynecological and Obstetrical Society. AGOS advances the health of women
by providing dedicated leadership and promoting excellence in research,
education and medical practice. AGOS is an organization comprised of
individuals attaining national prominence in scholarship in the
discipline of obstetrics, gynecology and women's health. Dr. Brewer was
inducted in recognition of her leadership in the field and outstanding
academic career. |
Joel Levine, M.D. |
 |
Gastroenterologist and colon cancer prevention expert
Joel Levine, M.D.,
was recently named one of America’s Top Doctors for Women.
Learn more > |
Zihai Li, M.D., Ph.D. |
 |
Zihai Li, M.D., Ph.D., a prominent
physician-researcher, was recently inducted into the American Society
for Clinical Investigation, one of the nation’s oldest and most
respected medical honor societies. The ASCI is dedicated to the
advancement of research that extends our understanding and improves the
treatment of human diseases, and members are committed to mentoring
future generations of physician-scientists. Induction into this society
is an honor in recognition of Dr. Li's research and academic career. |
Douglas Peterson, D.M.D., Ph.D. |
 |
Douglas Peterson, D.M.D., Ph.D., recently chaired an international
conference funded by the National Institutes of Health, on “Oral
Complications of Emerging Cancer Therapies.” This was only the second NIH-funded conference on this topic in 20 years. Approximately 115
people participated in the conference, including leading scientists and
faculty from the U.S., Europe, Australia and the Middle East, as well as
junior investigators and representatives of the NIH. Dr. Peterson will
summarize findings of the conference at an international meeting this
summer. |
Devon Pleau |
|
Devon Pleau, of the Department of Molecular Medicine, is co-chairing a
session on LCM sample preparation at an LC Forum in Boston this fall
(2009). |
Daniel Rosenberg, Ph.D. |
 |
Daniel Rosenberg,
Ph.D., research director of the Colon Cancer Prevention Program and
a professor of medicine in the Department of Genetics and Developmental
Biology, will present new information about cancer chemoprevention at
the 2009 AACR International Conference in Houston. Understanding the
mechanisms that govern the formation of precancerous colon lesions,
referred to as aberrant crypt foci, and their conversion to fully
malignant tumors is a long-term goal of Dr. Rosenberg’s laboratory. |
John Taylor IIII, M.D. |
 |
John Taylor IIII, M.D., one of the region’s few bladder cancer
specialists, has received a $729,000, five-year grant from the American
Cancer Society to support his research on the role of inflammatory
molecules on the development and progression of bladder cancer.
Learn more > |
Lori Wilson, M.D., F.A.C.S. |
 |
Lori Wilson, M.D., surgical director
of the Breast Cancer Program, has been elected to the American Cancer
Society’s New England Division Board of Directors, to serve a three-year
term starting September 1, 2009.
"Dr. Wilson has demonstrated a strong commitment to the fight against
cancer through her research in proteomics, an advanced approach to the
early detection of cancer," said Donald J. Gudaitis, CEO of the
Society's New England Division. |
|
|
